54

29th Annual American Uveitis Society Winter Symposium
Sarcoidosis: Ocular and Systemic Disease and Retinal and Systemic Vascular Inflammation

29th Annual American Uveitis Society Winter Symposium
Sarcoidosis: Ocular and Systemic Disease and Retinal and Systemic Vascular Inflammation

Datum
17.01.2026 - 19.01.2026
Symposium
Park City
Sprache
Englisch
Gebühren ab
400.00 EUR
Veranstalter
Medical Conference Planners, Inc.
Organisator

Medical Conference Planners, Inc.
1251 Post Road
US - 10583 Scarsdale, NY
Contact Name: Karen Baranick
Tel.: +1 914 722 0664
Fax: +1 914 931 1664

The 29th Annual American Uveitis Winter Symposium, open to members and non-members of the AUS, is a highly interactive scientific meeting that attracts uveitis and retina key opinion leaders and trainees in clinical practice, basic research, and translational research. The goal of the meeting is to provide a forum for the exchange of new information and ideas relevant to clinical practice and scientific investigation of patients with complex infectious and inflammatory ocular diseases.
  • Basisinformation
    Datum
    17.01.2026 - 19.01.2026
    Symposium
    Park City
    Sprache
    Englisch
    Gebühren ab
    400.00 EUR
    Veranstalter
    Medical Conference Planners, Inc.
    Organisator

    Medical Conference Planners, Inc.
    1251 Post Road
    US - 10583 Scarsdale, NY
    Contact Name: Karen Baranick
    Tel.: +1 914 722 0664
    Fax: +1 914 931 1664

  • VERANSTALTUNGSORT
    Westgate Park City Resort
    3000 Canyons Resort Dr.
    UT 84098 Park City, US
  • Programm

    The symposium will bring together over 110 academic uveitis and retina specialists, and fellows-in-training. The two main scientific sessions are Sarcoidosis: Ocular and Systemic Disease and Retinal and Systemic Vascular Inflammation, each of which include a stellar faculty.

    Saturday, January 17, 2026

    7:00 – 7:30 AM
    Registration & Breakfast

    7:00 – 9:50 AM
    Exhibits

    7:30 – 7:35 AM
    Opening Remarks
    Phoebe Lin, MD, PhD & Akbar Shakoor, MD

    7:35 – 9:50 AM
    CASE PRESENTATIONS, FREE PAPERS & DISCUSSION
    Moderator: Akbar Shakoor, MD

    7:35 – 7:39 AM
    Combined Retinal Vein and Artery Occlusion as an Initial Ocular Manifestation of IBD
    Kevin C. Allan, MD, PhD

    7:39 – 7:41 AM
    Discussion 

    7:41 – 7:45 AM
    When to Consider Opting Out of Systemic Steroids in Varicella Zoster Orbital Apex Syndrome: Outcomes for Two Cases
    Tyler A. Bahr, MD

    7:45 – 7:47 AM
    Discussion 

    7:47 – 7:51 AM
    Costly Delays: VZV Retinitis Complicated by Meningoencephalitis
    Matthew T. Griffin, MD

    7:51 – 7:53 AM
    Discussion

    7:53 – 8:03 AM
    Intravenous Immunoglobulin, but not Antimetabolite, Mitigates Visual Field Loss in Non-paraneoplastic Autoimmune Retinopathy
    Christopher R. Rosenberg, MD
    Travel Grant Awardee

    8:03 – 8:05 AM
    Discussion 

    8:05 – 8:14 AM
    Serum Protein Analysis in Autoimmune Retinopathy: A Pilot Study
    Timothy Boyce, MD

    8:14 – 8:16 AM
    Discussion 

    8:16 – 8:25 AM
    Pathogen-Associated Visual Outcomes Following Post-Procedure Endophthalmitis
    Christopher Conrady, MD, PhD

    8:25 – 8:27 AM
    Discussion 

    8:27 – 8:36 AM
    Vamikibart in Patients With Uveitic Macular Edema in the Phase 3 MEERKAT/SANDCAT Trials: Durability of Response 8 Weeks After the Last Per-Protocol Injection
    Brian K. Do, MD, FASRS

    8:36 – 8:38 AM
    Discussion

    8:38 – 8:42 AM
    Atypical Micrococcus Luteus Endophthalmitis
    Tedi Begaj, MD

    8:42 – 8:44 AM
    Discussion

    8:44 – 8:48 AM
    Intravitreal Corticosteroid-Associated Sequential C. Acnes Endophthalmitis and CMV Retinitis in an Immunocompetent Patient
    Samuel D. Levant, MD

    8:48 – 8:50 AM
    Discussion 

    8:50 – 8:54 AM
    An Unusual Masquerade
    Dev A. Parikh, MD

    8:54 – 8:56 AM
    Discussion

    8:56 – 9:00 AM
    Just a JIA uveitis flare?
    Amit K. Reddy, MD

    9:00 – 9:02 AM
    Discussion

    9:02 – 9:11 AM
    Clinical Relevance of a Modified UVEDAI Score in Stratifying Uveitis Severity and Prognosis
    Julia Goetz, BS

    9:11 – 9:13 AM
    Discussion 

    9:13 – 9:22 AM
    Intraocular B Cells May Drive Treatment Resistance in Uveitis
    Lynn M. Hassman, MD, PhD

    9:22 – 9:24 AM
    Discussion 

    9:24 – 9:33 AM
    Association of Eye Care Utilization and Social Determinants of Health Among Patients With Uveitis: A Cross-Sectional Factor Analysis
    Timothy Janetos, MD, MBA

    9:33 – 9:35 AM
    Discussion 

    9:35 – 9:39 AM
    Intermediate and Posterior Uveitis Choroidal Findings Using the HDR Widefield Fundus Camera
    Justine Cheng, MD

    9:39 – 9:41 AM
    Discussion

    9:41 – 9:45 AM
    Development of Central Nervous System Demyelination in a Patient With Vogt–Koyanagi–Harada Disease on TNF-α Blocker
    Alyssa Coleman, MD

    9:45 – 9:47 AM
    Discussion 

    9:47 – 9:50 AM
    Wrap Up
    Akbar Shakoor, MD

    9:50 – 10:00 AM
    Break

    10:00 AM – 12:00 PM
    Satellite Events

    11:00 AM - 2:00 PM
    Lunch on Own

    2:00 – 3:30 PM
    Case Discussion with Experts
    Moderator: Akbar Shakoor, MD

    3:30 – 4:00 PM
    Break

    3:30 PM – 7:40 PM
    Exhibits

    4:00 – 6:00 PM
    SCIENTIFIC SESSION 1: SURGICAL MANAGEMENT OF UVEITIS AND ITS COMPLICATIONS
    Moderator: Akbar Shakoor, MD

    4:00 – 4:05 PM
    Introduction of Dr. Julie Schallhorn
    Akbar Shakoor, MD

    4:05 – 4:50 PM
    Anterior Segment Surgery in Uveitis: From PUK to Premium IOLs
    Julie Schallhorn, MD, MS
    Keynote Speaker

    4:50 – 5:00 PM
    Discussion

    5:00 – 5:05 PM
    Introduction of Dr. Demetrios Vavvas
    Akbar Shakoor, MD

    5:05 – 5:50 PM
    Operating in a Firestorm: When and How
    Demetrios G. Vavvas, MD, PhD
    Keynote Speaker

    5:50 – 6:00 PM
    Discussion

    6:00 – 6:30 PM
    Break

    6:30 – 7:22 PM
    CASE PRESENTATIONS, FREE PAPERS & DISCUSSION
    Moderator: Phoebe Lin, MD, PhD

    6:30 – 6:34 PM
    Surgical Management of Coats-Like Response Secondary to Presumed Ocular Sarcoidosis Panuveitis
    Grant Justin, MD

    6:34 – 6:36 PM
    Discussion

    6:36 – 6:40 PM
    Pathogenic Mechanisms of Immune Checkpoint Inhibitor (ICI)-Associated Choroidal and Retinal Adverse Reactions
    Rachana Haliyur, MD, PhD

    6:40 – 6:42 PM
    Discussion

    6:42 PM – 6:46 PM
    Not Your Average Granuloma
    Jennifer C. Hu, MD

    6:46 – 6:48 PM
    Discussion

    6:48 – 6:57 PM
    Diagnostic Pars Plana Vitrectomy in Undifferentiated Uveitis: Systematic Review and Meta-Analysis
    Charles Zhang, MD

    6:57 – 6:59 PM
    Discussion 

    6:59 – 7:03 PM
    Sarcoid Uveitis Mimicking Birdshot Chorioretinopathy in an HLA-A29-Positive Patient
    Vasiliki Giannakakos, MD

    7:03 – 7:05 PM
    Discussion 

    7:05 – 7:09 PM
    Rapid Development of Cataract and Iris Neovascularization
    Jennifer L. Jung, MD

    7:09 – 7:11 PM
    Discussion 

    7:11 – 7:20 PM
    Comparative Risk of Glaucoma Interventions in Uveitis-Associated and Primary Open-Angle Glaucoma
    Brian Toy, MD

    7:20 – 7:22 PM
    Discussion 

    7:22 – 7:37 PM
    Industry Presentations

    7:37 – 7:40 PM
    Closing Remarks
    Phoebe Lin, MD, PhD

    7:40 PM
    End of Session

    7:45 – 10:00 PM
    Dinner at Westgate Park City

    Sunday, January 18, 2026

    7:00 – 7:30 AM
    Breakfast
     

    7:00 – 9:45 AM
    Exhibits

    7:30 – 7:35 AM
    Opening Remarks
    Phoebe Lin, MD, PhD

    7:35 – 9:50 AM
    CASE PRESENTATIONS, FREE PAPERS & DISCUSSION
    Moderator: Phoebe Lin, MD, PhD

    7:35 – 7:39 AM
    For Whom The Bell Tolls
    Jessica Kraker, MD, MS

    7:39 – 7:41 AM
    Discussion

    7:41 – 7:45 AM
    Reduction of Adalimumab Immunogenicity with Dose Escalation, Alternative to Combination Antimetabolite
    Jennifer Lee, MD

    7:45 – 7:47 AM
    Discussion 

    7:47 – 7:51 AM
    A Macular Star in the Periphery?
    Pauline T. Merrill, MD 

    7:51 – 7:53 AM
    Discussion 

    7:53 – 8:03 AM
    Choroidal OCT Biomarkers correlate with ERG Function in Birdshot Chorioretinopathy and Potentially Predict Reversible Retinal Function Decline
    Duriye Damla Sevgi, MD
    Travel Grant Awardee

    8:03 – 8:05 AM
    Discussion 

    8:05 – 8:14 AM
    Outcomes of Acute Zonal Outer Retinopathy in Patients with Multifocal Choroiditis
    Adina S. Kazan, MD

    8:14 – 8:16 AM
    Discussion 

    8:16 – 8:25 AM
    Identifying Distinct Blood Transcriptomic and Proteomic Signatures in Ocular Sarcoidosis and Birdshot Chorioretinopathy
    Shilpa Kodati, MD

    8:25 – 8:27 AM
    Discussion 

    8:27 – 8:36 AM
    Treatment Failure Rates: Humira vs Biosimilars
    Jared Moon, MD, MEd

    8:36 – 8:38 AM
    Discussion 

    8:38 – 8:42 AM
    Recalcitrant Posterior Uveitis Treated with Plasmapheresis
    David Merriott, MD 

    8:42 – 8:44 AM
    Discussion 

    8:44 – 8:48 AM
    Panuveitis and Anterior Uveitis as Manifestations of IgG4 Related Disease
    Sedona Rosenberg, MD

    8:48 – 8:50 AM
    Discussion 

    8:50– 8:54 AM
    Floaters - Shadows Before the Storm
    Lydia Sauer, MD, Dr. med.

    8:54 – 8:56 AM
    Discussion 

    8:56 – 9:00 AM
    Trust Your Gut: A Case of Bilateral Blurry Vision
    Kai Seely, MD

    9:00 – 9:02 AM
    Discussion 

    9:02 – 9:11 AM
    Prediction of Treatment Response in Birdshot Chorioretinopathy Using Artificial Intelligence
    Lingling Huang, MD, PhD

    9:11 – 9:13 AM
    Discussion 

    9:13– 9:22 AM
    Clinical Outcomes in Toxoplasmosis Chorioretinitis: Comparing Intravitreal Clindamycin with and without Adjunctive Steroids
    Sophia Lam, MD

    9:22 – 9:24 AM
    Discussion 

    9:24 – 9:33 AM
    Seasonal Incidence of New Uveitis Diagnoses Across the United States
    Justin Muste, MD

    9:33 – 9:35 AM
    Discussion 

    9:35 – 9:39 AM
    Inflammation in Unexpected Places
    Aumer Shughoury, MD

    9:39 – 9:41 AM
    Discussion 

    9:41 – 9:45 AM
    Running Out of GAS
    Marta Stevanovic, MD, MSc

    9:45 – 9:47 AM
    Discussion 

    9:47 – 9:50 AM
    Wrap Up
    Phoebe Lin, MD, PhD 

    9:50 – 10:00 AM
    Break

    10:00 AM – 12:00 PM
    Satellite Event 

    12:00 - 2:00 PM
    Lunch on Own

    2:00 – 3:30 PM
    Case Discussion with Experts
    Phoebe Lin, MD, PhD

    3:30 – 4:00 PM
    Break

    3:30 – 7:40 PM
    Exhibits

    4:00 – 6:00 PM
    SCIENTIFIC SESSION 2: DIAGNOSTICS AND MANAGEMENT OF PEDIATRIC UVEITIS
    Moderator: Phoebe Lin, MD, PhD

    4:00 – 4:05 PM
    Introduction of Dr. Jennifer Thorne
    Phoebe Lin, MD, PhD

    4:05  – 4:50 PM
    Clinical Outcomes in JIA-Associated Uveitis
    Jennifer E. Thorne, MD, PhD

    4:50 – 5:00 PM
    Discussion

    5:00 – 5:05 PM
    Introduction of Dr. Sheila Angeles-Han
    Phoebe Lin, MD, PhD

    5:05 – 5:50 PM
    A Bird's Eye View of JIA-Associated Uveitis: Diagnosis, Treatment, and Tear-Based Biomarkers
    Sheila T. Angeles-Han, MD, MSc

    5:50 – 6:00 PM
    Discussion

    6:00 – 6:30 PM
    Break

    6:30 – 7:22 PM
    Case Presentations, Free Papers, & Discussions
    Moderator: Akbar Shakoor, MD

    6:30 – 6:34 PM
    A Child with STAT3 Gain-Of-Function Mutation and Uveitis
    Pooja V. Bhat, MD

    6:34 – 6:36 PM
    Discussion 

    6:36 – 6:40 PM
    Targeting IL-17 to Treat Blau Syndrome
    Ruth Napier, PhD

    6:40 – 6:42 PM
    Discussion 

    6:42 – 6:46 PM
    Pediatric Multifocal Choroiditis with Panuveitis: A Multicenter Case Series
    Neda Dastgheyb, MD

    6:46 – 6:48 PM
    Discussion 

    6:48 – 6:57 PM
    Undifferentiated Pediatric Panuveitis: Clinical Characteristics, Management Strategies, and Outcomes from a Tertiary Referral Center
    Jacob C. Larsen, BS

    6:57 – 6:59 PM
    Discussion 

    6:59 – 7:03 PM
    Going with the Flow
    Becca Edwards, MD

    7:03 – 7:05 PM
    Discussion

    7:05 – 7:09 PM
    Recurrent Detachments in a Case of Intermediate Uveitis
    Debora Lee, MD

    7:09 – 7:11 PM
    Discussion 

    7:11 – 7:20 PM
    Incidence and Predictors of Remission of Childhood Uveitis in a Large Community Cohort
    Ying Qian, MD

    7:20 – 7:22 PM
    Discussion 

    7:22 PM – 7:37 PM
    Industry Presentations

    7:37 PM – 7:40 PM
    Closing Remarks
    Akbar Shakoor, MD

    7:40 PM
    End of Session

    Monday, January 19, 2026

    7:00– 7:30 AM
    Breakfast
     

    7:30 – 7:35 AM
    Opening Remarks
    Akbar Shakoor, MD

     7:35– 9:30 AM
    CASE PRESENTATIONS, FREE PAPERS & DISCUSSION
    Moderator: Akbar Shakoor, MD

     7:35 – 7:44 AM
    Investigation of Psoriasis and Psoriatic Arthritis in a Uveitis Clinic
    Jonathan Ji, BS 

    7:44 – 7:46 AM
    Discussion 

    7:46 – 7:50 AM
    Atypical MEWDS Referral
    Alexander M. Rusakevich, DO

    7:50 – 7:52 AM
    Discussion 

    7:52– 7:56 AM
    BRVO in an Immunocompromised Patient
    Pelin Celiker, MD

    7:56 – 7:58 AM
    Discussion 

    7:58 – 8:02 AM
    Suprachoroidal Triamcinolone (XIPERE) for Rapidly Progressive Placoid Chorioretinitis
    Andrew Briere, DO

    8:02 – 8:04 AM
    Discussion

    8:04 – 8:14 AM
    An Optimized Artificial Intelligence Model to Distinguish Vitreoretinal Lymphoma from Non-Infectious Uveitis
    Ogul E. Uner, MD
    Travel Grant Awardee

    8:14 – 8:16 AM
    Discussion 

    8:16 – 8:20 AM
    Purtscher‐Like Retinopathy Presenting like Pseudo-Retinitis: A Rare Presentation of Hematopoietic Stem Cell Transplant‐Associated Thrombotic Microangiopathy
    Marie Helene H. Errera, MD, PhD

    8:20 – 8:22 AM
    Discussion 

    8:22 – 8:26 AM
    Retinal Whitening with a Negative Tap
    Hosannah Evie, MD

    8:26 – 8:28 AM
    Discussion 

    8:28 – 8:32 AM
    Fulminant Bilateral Frosted Branch Angiitis in a Pediatric Patient
    Asad Loya, MD

    8:32 – 8:34 AM
    Discussion 

    8:34 – 8:43 AM
    Efficacy of Janus Kinase Inhibitors for Non-Infectious Uveitis
    Umangi Patel, MD

    8:43 – 8:45 AM
    Discussion 

    8:45 – 8:54 AM
    Safety of Anti-VEGF Injections in Patients with Uveitis
    Mitchell Allphin, MD

    8:54 – 8:56 AM
    Discussion 

    8:56 – 9:05 AM
    Outcomes of Acute Retinal Necrosis: ARN Cohort Study
    Carl S. Wilkins, MD

    9:05 – 9:07 AM
    Discussion 

    9:07 – 9:16 AM
    The Role of Methotrexate on Preventing Proliferative Vitreoretinopathy Following Retinal Detachment Repair
    Melissa Yuan, MD

    9:16 – 9:18 AM
    Discussion 

    9:18 – 9:30 AM
    Closing Remarks
    Phoebe Lin, MD, PhD & Akbar Shakoor, MD

     

     

     

  • Gebühren
    Fachärzte/-innen
    Gebühren ab
    1.200,00 EUR
    Early Bird bis 18.11.2025
    700,00 EUR
    Ärzte/-innen in Weiterbildung
    Gebühren ab
    450,00 EUR
    Early Bird bis 18.11.2025
    400,00 EUR
    Registration fee includes Breakfast, Breaks, and Saturday Dinner
  • Buchung / Anmeldung

    Registration required. Please contact the organizer for further information.

  • Zertifizierung
    Zertifizierung unbekannt
  • Sponsoren

    ABBVIE
    ani Pharmaceuticals, Inc.
    Bausch+Lomb
    Keenova
    Amgen
    Apellis
    Regeneron
    EyePoint
    Retina Consultans of America

Veranstaltung teilen